CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 71,362 shares at $2.76 ($196,859)
- 4 Open-market sale 10% owner sold 398,133 shares at an average $2.98 ($1,185,886)
- 4 Open-market buy Chief Medical Officer bought 110,000 shares at $2.25 ($247,500)
- 4 Open-market buy Director bought 20,000 shares at $1.87 ($37,400)
- 4 Open-market buy Chief Medical Officer bought 200,000 shares at an average $1.55 ($309,000)
- 4 Open-market buy Director bought 19,400 shares at $1.29 ($25,026)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $1.29 ($32,250)
- 4 Open-market buy SVP Finance, CFO bought 20,000 shares at $1.06 ($21,200)
- 4 Open-market buy SVP of Research, CSO bought 45,045 shares at $1.17 ($52,703)
- 4 Open-market buy SVP, Chief Business Officer bought 6,500 shares at $1.05 ($6,825)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 14 of 34 · 678 filings